{"id":660,"date":"2026-05-19T16:34:50","date_gmt":"2026-05-19T07:34:50","guid":{"rendered":"https:\/\/www.med.osaka-u.ac.jp\/pub\/gh\/?p=660"},"modified":"2026-05-21T11:01:24","modified_gmt":"2026-05-21T02:01:24","slug":"%e7%ac%ac41%e5%9b%9e-osaka-liver-forum%ef%bc%88olf%ef%bc%89%e3%82%92%e9%96%8b%e5%82%ac%e3%81%97%e3%81%be%e3%81%97%e3%81%9f","status":"publish","type":"post","link":"https:\/\/www.med.osaka-u.ac.jp\/pub\/gh\/en\/news\/2026\/05\/19\/660\/","title":{"rendered":"The 41st Osaka Liver Forum (OLF) was held"},"content":{"rendered":"

\n The 41st OLF (Osaka Liver Forum) Research and Presentation Meeting was held on Friday, May 15, 2026, at RIHGA Royal Hotel Osaka West Wing, 2nd floor \"Sanraku no Ma\". The event was attended by many doctors and was a great success, with lively discussions and exchanges of opinions on liver disease treatment and research.\n<\/p>\n

\n A wide variety of topics were presented in this program, including immunotherapy for unresectable hepatocellular carcinoma, the relationship between MASLD and sleep apnea syndrome (OSA), retention rate in alcoholic cirrhosis, prediction of treatment efficacy of combined immunotherapy for liver cancer, and search for new biomarkers in chronic hepatitis B. Both the young researchers' and general sessions were very active, and the discussions were very meaningful for the development of daily practice and future research.\n<\/p>\n

\n We would like to express our sincere appreciation to all the speakers and participants, as well as to all those who worked so hard to make this event possible.
\n OLF (Osaka Liver Forum) will continue to provide a forum for academic exchange that contributes to the development of medical treatment and research in the field of liver disease.\n<\/p>\n

Program<\/h3>\n
\n